IRIS UniCatt

Gambacorta, Maria Antonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.191
EU - Europa 10.462
AS - Asia 10.177
SA - Sud America 1.953
AF - Africa 350
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 16
Totale 35.203
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.837
SG - Singapore 4.629
DE - Germania 3.183
CN - Cina 2.014
SE - Svezia 1.655
BR - Brasile 1.586
IT - Italia 1.401
VN - Vietnam 1.130
FR - Francia 878
NL - Olanda 768
IN - India 639
GB - Regno Unito 513
IE - Irlanda 458
UA - Ucraina 370
FI - Finlandia 321
ID - Indonesia 308
JP - Giappone 280
HK - Hong Kong 255
PL - Polonia 202
RU - Federazione Russa 197
CA - Canada 163
AR - Argentina 138
BD - Bangladesh 138
TR - Turchia 135
IQ - Iraq 130
MX - Messico 121
AT - Austria 95
BE - Belgio 95
PK - Pakistan 83
ZA - Sudafrica 83
KR - Corea 68
CI - Costa d'Avorio 66
ES - Italia 64
CZ - Repubblica Ceca 59
EC - Ecuador 47
PH - Filippine 42
MA - Marocco 41
AU - Australia 40
CO - Colombia 40
SA - Arabia Saudita 40
VE - Venezuela 38
IR - Iran 36
LT - Lituania 36
CL - Cile 31
KE - Kenya 30
CH - Svizzera 29
UZ - Uzbekistan 29
EG - Egitto 25
JO - Giordania 25
PE - Perù 24
IL - Israele 23
AE - Emirati Arabi Uniti 22
RO - Romania 21
TN - Tunisia 21
DZ - Algeria 20
UY - Uruguay 20
PY - Paraguay 19
GR - Grecia 17
MY - Malesia 17
AL - Albania 15
AZ - Azerbaigian 15
PA - Panama 15
KZ - Kazakistan 14
NZ - Nuova Zelanda 14
ET - Etiopia 13
BG - Bulgaria 11
JM - Giamaica 11
NP - Nepal 11
SN - Senegal 11
BH - Bahrain 10
NG - Nigeria 10
RS - Serbia 10
AM - Armenia 9
CR - Costa Rica 9
DO - Repubblica Dominicana 9
PS - Palestinian Territory 9
TW - Taiwan 9
BO - Bolivia 8
HN - Honduras 8
NO - Norvegia 8
OM - Oman 8
PT - Portogallo 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
A2 - ???statistics.table.value.countryCode.A2??? 7
DK - Danimarca 7
EU - Europa 7
GE - Georgia 7
HU - Ungheria 7
KG - Kirghizistan 6
LK - Sri Lanka 6
AO - Angola 5
MN - Mongolia 5
MT - Malta 5
NI - Nicaragua 5
BY - Bielorussia 4
LB - Libano 4
LV - Lettonia 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 35.143
Salva come PNG Salva come JPEG
Città #
Singapore 2.615
Chandler 1.765
Ashburn 1.193
San Jose 1.145
Amsterdam 708
New York 459
Dublin 455
Beijing 451
Ho Chi Minh City 401
Los Angeles 348
Frankfurt am Main 307
Rome 303
The Dalles 288
Lauterbourg 278
Ann Arbor 274
Hanoi 261
Jakarta 260
Tokyo 258
Jacksonville 252
Milan 248
Hyderabad 247
San Mateo 243
Munich 237
Hong Kong 220
Hefei 218
Wilmington 172
São Paulo 156
Boston 148
Princeton 144
Warsaw 143
Helsinki 138
Nanjing 135
Nürnberg 131
Houston 121
St Louis 121
Moscow 119
Marseille 118
Dallas 117
Bremen 112
Cattolica 112
Dearborn 109
Chicago 105
Woodbridge 103
Fairfield 94
Santa Clara 92
Council Bluffs 90
Brussels 88
Redwood City 81
Buffalo 78
London 78
Da Nang 71
Seattle 71
Brooklyn 67
Orem 67
Abidjan 66
Lawrence 66
Seoul 63
Turku 63
Nuremberg 62
Kent 58
Izmir 53
Atlanta 49
Denver 49
Nanchang 49
Paris 49
Toronto 49
Vienna 49
Düsseldorf 47
Leawood 47
Montreal 47
Phoenix 47
Chennai 46
Haiphong 46
Lappeenranta 45
Washington 45
Johannesburg 44
Rio de Janeiro 43
Stockholm 43
Baghdad 42
Boardman 42
Zhengzhou 41
North Bergen 40
Poplar 39
Shenyang 38
Augusta 35
Brno 35
Detroit 35
Manchester 33
Falkenstein 32
Guangzhou 32
Columbus 31
Falls Church 30
Norwalk 30
Pune 30
Tianjin 30
Belo Horizonte 29
San Francisco 29
Dhaka 28
Mexico City 28
Nairobi 28
Totale 18.577
Salva come PNG Salva come JPEG
Nome #
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 944
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 505
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 500
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 372
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 310
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 266
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 231
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 226
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 220
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 219
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 219
Multimodality treatment of unresectable stage III non small cell lung cancer: interim analysis of a phase II trial using preoperative gemcitabine with concurrent radiotherapy 218
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 216
Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial. 209
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 207
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 205
Lung recruitment strategies and surfactant in neonatal intensive care unit 197
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 196
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 194
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 191
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 191
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 189
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 187
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 186
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 186
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 185
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 181
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 179
Generator breast datamart—the novel breast cancer data discovery system for research and monitoring: Preliminary results and future perspectives 178
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 177
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 175
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 175
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 174
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 173
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 171
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 171
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 170
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 168
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 167
The assisi think tank meeting breast large database for standardized data collection in breast cancer—attm.Blade 164
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 163
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 161
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 159
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 155
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma 152
THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis 150
Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications 149
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach 149
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 149
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 149
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 147
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases 147
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 146
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes 146
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 146
An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine 145
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 145
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 145
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 144
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 143
A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer 143
The impact of radiomics in diagnosis and staging of pancreatic cancer 143
The INTER-ROMA project--a survey among Italian radiation oncologists on their approach to the treatment of bone metastases 142
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 142
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 142
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 140
BRIDGE -1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial 139
MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation 138
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 138
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 137
Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: A multicentric prospective study with external validation. 137
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 137
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 136
Integration of art and technology in personalized radiation oncology care: Experiences, evidence, and perspectives 135
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 135
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 135
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases 134
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. 134
Virtual simulation:fifteen years later 134
Magnetic resonance–guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system 134
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 133
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 133
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum 132
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 132
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 132
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 131
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 131
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy 131
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 130
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 130
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer 130
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 129
Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): Single institution experience and systematic literature review 129
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 129
Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey 128
Avatar: Analysis for visual acuity prediction after eye interventional radiotherapy 128
IGRT in rectal cancer. 127
Perspectives and limits of cancer treatment in an oldest old population 127
An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis 127
Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer 126
Totale 17.732
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.139
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021276 0 0 0 0 0 0 0 0 0 68 161 47
2021/20222.000 179 77 35 163 84 68 32 266 132 142 440 382
2022/20234.910 641 644 369 762 272 584 257 388 575 153 189 76
2023/20242.637 106 684 127 185 129 460 164 94 31 95 274 288
2024/20255.795 112 149 411 219 582 230 233 228 764 696 1.230 941
2025/202615.272 2.028 447 871 1.699 2.522 2.298 2.640 888 972 907 0 0
Totale 35.706